Clinical trial · Interventional
Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma
Comparison of Zero Ischemia Laparoscopic Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma
NCT02326558CI-TRIAL-00026801completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the feasibility, safety and efficiency of zero ischemia laparoscopic microwave ablation-assisted enucleation in comparison with conventional laparoscopic partial nephrectomy in the treatment of T1a renal cell carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| conventional laparoscopic partial nephrectomy | Procedure | — | UNRESOLVED |
| laparoscopic microwave ablation-assisted enucleation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- microwave enucleation
- description
- zero ischemia laparoscopic microwave ablation-assisted enucleation of the tumor
- interventionNames
- Procedure: laparoscopic microwave ablation-assisted enucleation
- type
- ACTIVE_COMPARATOR
- label
- laparoscopic partial nephrectomy
- description
- conventional laparoscopic partial nephrectomy with clamping of the renal artery
- interventionNames
- Procedure: conventional laparoscopic partial nephrectomy
Primary outcomes (1)
- measure
- absolute change in glomerular filtration rate (GFR) of the affected kidney
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * patients with sporadic, unilateral, newly diagnosed T1a presumed renal cell carcinoma * exophytic cancer * distance from the hilar renal vessels and urinary collecting system \>= 1cm * patients with normal contralateral renal function (differential renal function of \>40% as determined by renal scintigraphy) * patients giving consent to the participation in the current clinical trial Exclusion Criteria: * patients with a history of other renal diseases, such as urinary lithiasis * patients with a history of renal surgery
References
Publications (0)
Data not yet available
No reference posted for this study.